Results 1 to 10 of about 19,420 (250)

Examining the predictive validity of alcohol-seeking following punishment-imposed abstinence in mice. [PDF]

Alcohol Clin Exp Res (Hoboken)
Animal models of alcohol use disorder are critical to understand the neurochemical mechanisms underlying this disorder to inform targeted medication development. However, quite often the validity of commonly used animal models remains untested. Here, we optimized a highly used model of abstinence in mice and demonstrated the predictive validity of the ...
Tran L, Kuznetsova M, Manning EE, Campbell EJ.   +3 more
europepmc   +2 more sources

Thoracic Society of Australia and New Zealand (TSANZ) Guidance for the Management of Electronic Cigarette Use (Vaping) in Adolescents and Adults. [PDF]

Respirology
ABSTRACT Electronic cigarette (EC) use, especially among younger members of society, has grown to concerning levels in many countries, including Australia and New Zealand. Uptake in the general population, driven by technological and pharmacological innovations, and accelerated by aggressive tobacco/vaping industry marketing, has outpaced medical ...
Marshall H, Vandeleur M, Dean E, Barton C, Luxton N, Carson-Chahhoud K, Schultz A, Williams J, Grammatopoulos T, Stone E, Shah S, Jones S, McDonald CF, Peters M.   +13 more
europepmc   +2 more sources

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. [PDF]

, 2012
n/
DE MICHELE, GIUSEPPE, FILLA, ALESSANDRO, SACCA', FRANCESCO   +2 more
core   +3 more sources

Integration of Tobacco Treatment Services into Cancer Care at Stanford. [PDF]

, 2020
As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 ...
Fielding-Singh, Priya, Gali, Kathleen, Jimenez, Kayla, Kendra, Matthew S, Mirkin, Rachelle, Pike, Brittany, Prochaska, Judith J, Tran, Cindy   +7 more
core   +2 more sources

Neural signatures of cognitive flexibility and reward sensitivity following nicotinic receptor stimulation in dependent smokers : a randomized trial [PDF]

, 2017
IMPORTANCE Withdrawal from nicotine is an important contributor to smoking relapse. Understanding how reward-based decision making is affected by abstinence and by pharmacotherapies such as nicotine replacement therapy and varenicline tartrate may aid ...
Aronson, Sarah E., Lesage, Elise, Ross, Thomas J., Salmeron, Betty Jo, Stein, Elliot A., Sutherland, Matthew T.   +5 more
core   +2 more sources

Nicotine-replacement therapy: A proven treatment for smoking cessation [PDF]

, 2010
Smoking is a major cause of cardiovascular diseases, respiratory diseases and cancer. Despite the high prevalence of smokers worldwide, smokers are often neglected and not offered effective assistance with quitting their habits. In order to overcome this
Robson, Noorzurani
core   +1 more source

Implementation of a quality improvement project on smoking cessation reduces smoking in a high risk trauma patient population. [PDF]

, 2016
BackgroundCigarette smoking causes about one of every five deaths in the U.S. each year. In 2013 the prevalence of smoking in our institution's trauma population was 26.7 %, well above the national adult average of 18.1 % according to the CDC website. As
Carrens, Karen, Doben, Andrew, Gross, Ronald, Korntner, Samuel, Nahmias, Jeffry, Poola, Shiva   +5 more
core   +1 more source

Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis [PDF]

, 2014
BACKGROUND: Varenicline is probably the most effective smoking cessation pharmacotherapy, but is less widely used than nicotine replacement therapy. We therefore set out to identify the characteristics of numerically important groups of patients who ...
Action on Smoking and Health (ASH), AE Evins, British National Formulary (BNF), G Taylor, GD Garrison, IH Witten, John Britton, JS Taggar, K Cahill, KH Thomas, L Szatkowski, M Ragg, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), R Peters, RM Anthenelli, Royal College of Physicians & Royal College of Psychiatrists, Sarah Lewis, TE Langley, The NHS Information Centre for Health and Social Care, U.S. Food and Drug Administration (FDA), UM Mohanasundaram, Y Huang, Yue Huang   +24 more
core   +3 more sources

Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP. [PDF]

, 2015
Cys-loop receptors are the site of action of many therapeutic drugs. One of these is the smoking cessation agent varenicline, which has its major therapeutic effects at nicotinic acetylcholine (nACh) receptors but also acts at 5-HT3 receptors.
Lillestol, Reidun K, Lummis, Sarah CR, Price, Kerry L, Ulens, Chris   +3 more
core   +3 more sources

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial [PDF]

, 2013
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
A McEwen, AC Farley, Al-Rehan Dhanji, D Gonzales, DE Jorenby, H McRobbie, Hayden McRobbie, HJ Aubin, JA Stapleton, JJ Prochaska, JO Ebbert, K Cahill, Katie Myers Smith, L Bauld, LF Stead, MC Fiore, N Lindson, P Hajek, P Hajek, Peter Hajek, R West, R West, R West, S Shiffman, S Shiffman, T Health, TF Heatherton   +26 more
core   +2 more sources